Skip to main content
Value Creator Interview OPOS

Optos, with Douglas Anderson and Anne Glover

Anne Glover is CEO of Amadeus Capital Partners. This is the story of how she saw the potential in Douglas Anderson’s break through optical medical device concept to create a world leading business from scratch. Optos has since saved the sight of, perhaps, millions of people.

A lot is written about how venture capital works, but this very human story conveys so well the uncertainty and challenges, as well as the judgement and persistence that it takes, to build a truly valuable company from scratch.

Anne Glover is the CEO of Amadeus Capital Partners, and her journey with Douglas Anderson’s breakthrough optical medical device concept is a testament to the unpredictable nature of venture capital, as well as the determination and foresight required to transform an innovative idea into a global success story.

This narrative begins with Anne Glover recognizing the immense potential in Douglas Anderson’s groundbreaking optical medical device concept.

At its inception, this technology held the promise of revolutionizing eye care and, in the process, potentially saving the sight of countless individuals.

This was more than just a business opportunity; it was a chance to make a significant and lasting impact on people’s lives.

The journey was far from straightforward, filled with uncertainties and challenges that are inherent to the world of venture capital.

Anne Glover and her team at Amadeus Capital Partners embarked on a remarkable endeavor to turn this concept into a thriving business.

This endeavor demanded not only financial investment but also the strategic acumen to navigate the complex landscape of healthcare technology and innovation.

Through moments of doubt and setbacks, Anne’s judgment and persistence played a pivotal role in shaping the future of this venture.

She had the foresight to see beyond the initial hurdles and recognize the long-term potential of the optical medical device.

Her unwavering commitment to the project, coupled with her ability to rally resources and expertise, allowed the concept to evolve into a world-leading enterprise.

The resulting company, known as Optos, stands as a testament to Anne Glover’s vision and dedication.

With its groundbreaking technology, Optos has indeed saved the sight of potentially millions of people around the world.

The story of Anne Glover, Douglas Anderson, and Optos is a powerful reminder that behind every successful venture capital endeavor, there is a human story filled with determination, resilience, and the pursuit of making a positive impact on society.

It illustrates that building a truly valuable company from scratch is not just about financial gains but also about transforming lives and leaving a lasting legacy.

Hans Lovrek: private equity’s precedent

Private equity’s approach to investment is much older than you think. Hans Lovrek sheds light on how the limited partnership has borrowed the essential features from some timeless approaches to managing risk amid uncertainty, asymmetry and opportunity.